-
Security Type
-
Convertible Note
-
Categories
-
Retail, Life Sciences, Education, Sports & Fitness
-
Min Investment
-
$100
-
Expected Close Date
-
April 30, 2022
-
Target Raise
-
$150.00K-$500.00K
-
Security Price
-
$1
- Number of Employees
- 3
- Cash
- $138,353
- Revenue
- $0
- Short Term Debt
- $111,125
- Cost of Goods
- $15,565
- Long Term Debt
- $279,500
- Net Income
- $-277,273
Company Description
🌏 Socially responsible vision of bringing relief to Covid sufferers in India
👌 Formula ingredients already proven to have both prophylactic and therapeutic effects on Covid-19
⭐️ Applying for registration in India to sell to an 800-million-person market of current AYUSH users
🎇 Utilizes Molecular Signaling™, an innovative discovery for viral symptoms
🏆 An incredible team of pharmaceutical and biotech startup veterans
💪 $250,000 already invested by founding team
✈️ Future plans include expansion to a large number of other countries
🙌 Molecular Signaling™ can address other viral infections including colds, flu, dengue fever, and Bell’s Palsy.
Key Deal Facts
🌏 Socially responsible vision of bringing relief to tens of millions who cannot afford other treatments
👌 Formula ingredients already proven to have both prophylactic and therapeutic effects on Covid-19
⭐️ Will be applying for AYUSH registration in India to serve an 800-million-person market of current AYUSH users
🎇 Utilizes Molecular Signaling™, an innovative discovery for viral symptoms
🏆 An incredible team of pharmaceutical and biotech startup veterans
💪 $250,000 already invested by founding team
✈️ Future plans include expansion to a large number of other countries
🙌 Molecular Signaling™ can address other viral infections including colds, flu, dengue fever, and Bell’s Palsy.
Use of Proceeds
$150,000 |
7.5 % Wefunder fee ($11,250)
92.5% Application for AYUSH license in India, formulation and manufacturing in India. ($138,750)
|
$250,000 |
7.5 % Wefunder fee ($18,750)
55.5% Application for AYUSH license in India, formulation, and manufacturing in India. ($138,750)
37% Social Media and Public Relations Marketing in India. ($92,500)
|
$500,000 |
7.5 % Wefunder fee ($37,500)
28% Application for AYUSH license in India, formulation, and manufacturing in India. ($138,750)
64.5% Social Media and Public Relations Marketing across multiple provinces in India. ($322,500)
|